Business StandardCenter·
₹7,000 crore bulk-drug scheme in the works to boost value chain
New ₹7,000 crore scheme may extend incentives to existing plants, adopt a platform-based approach and boost R&D in bulk-drug manufacturing
Read at Business Standard →


